ThE possibility that cultured keratinocytes produce endothelins were investigated. The results showed that cultured keratinocytes derived from normal human skin produce endothelin-1. Moreover, keratinocyte endotheHn-1 production was completely inhibited by the presence of actinomycin D in the medium. As in the case of endothelial cells, recombinant interleukin-l[ was capable of promoting endothelin-1 production in keratinocytes, whereas herapin inhibited it. Thrombin also inhibited endothelin-1 production. These results indicate that the mechanism of endothelin-1 production in keratinocytes is slightly different from the mechanism in vascular endothelial cells.
Introduction
Endothelin is a peptide that causes potent contraction of vascular smooth muscle. Endothelin not only has a potent constricting action on smooth muscle cells, but appears to promote arachidonic acid metabolism and the production of endothelium-derived relaxing factor (EDRF). Moreover, its promotion of fibroblast proliferation has been confirmed in vitro.
Although endothelin was previously thought to be a specific product of vascular endothelial cells. It has since been found to be produced by tracheal epithelial cells and nerve cells in the central nervous 45 system, where it acts as a neurotransmitter.. Re- cently, the authors proposed that endothelin-1 may participate as an inflammatory mediator because endothelin-like immunoreactants or endothelin-1 appeared and increased at the wound surface after thermal injury. Thus endothelin-1 may be capable of regulating various cell functions, however, it is still not clear whether keratinocytes produce endothelin-1.
In the present study, the authors investigated endothelin-1 production by cultured human keratinocytes and the mechanisms regulating it.
Materials and Methods
Keratinocyte cultures: Excess skin obtained during plastic surgery (in particular skin grafting) was made available to culture normal human keratinocytes. The skin was finely cut (4 x 4 mm) and after being disinfected in 10% providone-iodine solution (Meiji Seika Co., Tokyo, Japan) for 2 min, it was exposed to phosphate-buffered saline (PBS, Dainihon Seiyaku Co., Tokyo, Japan) at ambient temperature for 10 min containing 0.02% disodium ethylene diamine tetraacetate (EDTA; Dojin Chemical Co., Tokyo, Japan). The minced skin was then digested in Dulbecco's modified Eagle medium (DME; Gibco BRL Co., Grand Island, NY) containing 0.25% trypsin (Gibco BRL) for 18 h at 4C, and washed twice with PBS. The enzyme-treated skin was stirred for I h in DME medium containing 20% foetal calf serum (Gibco BRL), antibiotics (penicillin G, kanamycin (Meiji Seika) and amphotericin B (Gibco BRL)), was filtered through a Cell strainer (Becton Dickinson Japan Co., Tokyo, Japan), and the skin residue was removed. Thus keratinocytes were obtained from skin as free cells. The free cell suspension was then centrifuged at 1200 r.p.m, for 5min at 4C. Keratinocyte (2) this IL-1 stimulates endothelin-1 production by keratinocytes; and (3) the endothelin-1 promotes the proliferation or activation of tyrosinase in melanocytes; and finally (4) these processes may be a factor in the development of pigmentation in vivo. However, they also indicated that the mechanism of endothelin-1 production and secretion differs slightly from that observed in vascular endothelial cells. Future detailed studies on the influence of cell differentiation and skin inflammation on endothelin-1 production, including the problems raised by this study, are required.
